Delivery Order SPE2DB20D3111-SPE2DB24FA6UF
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.23 firm fixed price delivery order is for the supply of 4,568,682,890 units of CEPHALEXIN 250 MG/5 ML SUSP 100ML, a common antibiotic medication. The contract has an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp is a for-profit organization based in Conshohocken, Pennsylvania and is...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of CEPHALEXIN 250 MG/5 ML SUSP 100ML to the Defense Logistics Agency (DLA). The $3,355.33 Firm Fixed Price delivery order (SPE2DB20D2001|SPE2DB23FM53P) has a completion date of May 16, 2023 and was awarded on May 15, 2023. Amerisourcebergen is the prime contractor, and the contract has no set-aside designation, indicating open competition. Amerisourcebergen is a subsidiary of the...
- This federal contract award, valued at $4,617.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1106|SPE2DB24FDPB7) for the supply of 4562972846 - CEPHALEXIN 250 MG/5 ML SUSP 200ML, with a completion date of December 4, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,483.90 firm fixed-price delivery order is for the supply of 4562661923 ! CEPHALEXIN 250 MG/5 ML SUSP 200ML, a generic pharmaceutical product. The ultimate completion date for the contract is November 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $3,725.08, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of CEPHALEXIN 250 MG/5 ML SUSP 200ML, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in...
- This federal contract award, valued at $5,862.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEPHALEXIN 250 MG/5 ML SUSP 200ML, a pharmaceutical product. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,680.55 firm fixed-price delivery order is for the supply of 4563895362 CEPHALEXIN 250 MG/5 ML SUSP 200ML, with a performance period ending on March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, with the ID SPE2DX15D3402|SPE2DX24F1KFM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $19,667.03, is for the delivery of CEPHALEXIN 250 MG/5 ML SUSP 200ML, a pharmaceutical product, with a period of performance through December 27, 2023. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,003.84, is for the delivery of 4562291434 - CEPHALEXIN 250 MG/5 ML SUSP 200ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,689.81 firm fixed-price delivery order is for the supply of 4560484281 - CEPHALEXIN 250 MG/5 ML SUSP 100ML, a generic antibiotic medication. The contract has an ultimate completion date of April 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB24FA6UFDelivery Order
This federal contract award is for the delivery of 4,563,785,586 units of CEPHALEXIN 250 MG/5 ML SUSP 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,354.00 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit organization that serves as a prime contractor for pharmaceutical and medical supply contracts with U.S. government agencies, primarily the Department of Defense. This contract does not have a set-aside designation and is expected to be completed by February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/27/24 |